Loss of membrane-bound serine protease inhibitor HAI-1 induces oral squamous cell carcinoma cells' invasiveness

Journal of Pathology

Volumn 228, Issue 2, 2012, Pages 181-192

  Baba, Takashi ^a,b   Kawaguchi, Makiko ^a   Fukushima, Tsuyoshi ^a   Sato, Yuko ^c   Orikawa, Hiroshi ^a,b   Yorita, Kenji ^a   Tanaka, Hiroyuki ^a   Lin, Chen Yong ^d   Sakoda, Sumio ^b   Kataoka, Hiroaki ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b UNIVERSITY OF MIYAZAKI   (Japan)

^c Miyazaki Prefectural Industrial Support Foundation   (Japan)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

epithelial to mesenchymal transition; HAI 1; invasion; matriptase; oral squamous cell carcinoma

Indexed keywords

CALVASCULIN; CD24 ANTIGEN; DUAL SPECIFICITY PHOSPHATASE 6; HGF ACTIVATOR INHIBITOR; MATRIPTASE; SERINE PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER CELL CULTURE; CANCER TISSUE; CARCINOGENICITY; CARCINOMA CELL; CELL INVASION; CELL MIGRATION; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; GENE EXPRESSION; GENE SILENCING; GROWTH INHIBITION; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; MESENCHYME CELL; MOUTH SQUAMOUS CELL CARCINOMA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE KNOCKDOWN TECHNIQUES; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROTEINASE INHIBITORY PROTEINS, SECRETORY; SERINE ENDOPEPTIDASES;

EID: 84866237333     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.3993     Document Type: Article

References (49)

1. Parkin DM, Bray F, Ferlay J, et al., Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
2. Cooper JS, Pajak TF, Forastiere AA, et al., Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 2004; 350: 1937-1944.
3. Duffy MJ, McGowan PM, Gallagher WM,. Cancer invasion and metastasis: changing views. J Pathol 2008; 214: 283-293.
4. Bugge TH, Antalis TM, Wu Q,. Type II transmembrane serine proteases. J Biol Chem 2009; 284: 23177-23181.
5. Szabo R, Rasmussen AL, Moyer AB, et al., c-Met-induced epithelial carcinogenesis is initiated by the serine protease matriptase. Oncogene 2011; 30: 2003-2016.
6. Wu SR, Cheng TS, Chen WC, et al., Matriptase is involved in ErbB-2-induced prostate cancer cell invasion. Am J Pathol 2010; 177: 3145-3158.
7. Li W, Wang BE, Moran P, et al., Pegylated kunitz domain inhibitor suppresses hepsin-mediated invasive tumor growth and metastasis. Cancer Res 2009; 69: 8395-8402.
8. List K, Szabo R, Molinolo A, et al., Deregulated matriptase causes ras-independent multistage carcinogenesis and promotes ras-mediated malignant transformation. Genes Dev 2005; 19: 1934-1950.
9. Shimomura T, Denda K, Kitamura A, et al., Hepatocyte growth factor activator inhibitor, a novel Kunitz-type serine protease inhibitor. J Biol Chem 1997; 272: 6370-6376.
10. Kataoka H, Miyata S, Uchinokura S, et al., Roles of hepatocyte growth factor (HGF) activator and HGF activator inhibitor in the pericellular activation of HGF/scatter factor. Cancer Metast Rev 2003; 22: 223-236.
11. Kataoka H, Kawaguchi M,. Hepatocyte growth factor activator (HGFA): pathophysiological functions in vivo. FEBS J 2010; 277: 2230-2237.
12. Kataoka H, Suganuma T, Shimomura T, et al., Distribution of hepatocyte growth factor activator inhibitor type 1 (HAI-1) in human tissues. Cellular surface localization of HAI-1 in simple columnar epithelium and its modulated expression in injured and regenerative tissues. J Histochem Cytochem 1999; 47: 673-682.
13. Nagaike K, Kawaguchi M, Takeda N, et al., Defect of hepatocyte growth factor activator inhibitor type 1/serine protease inhibitor, Kunitz type 1 (Hai-1/Spint1) leads to ichthyosis-like condition and abnormal hair development in mice. Am J Pathol 2008; 173: 1464-1475.
14. Lin CY, Anders J, Johnson M, et al., Purification and characterization of a complex containing matriptase and a Kunitz-type serine protease inhibitor from human milk. J Biol Chem 1999; 274: 18237-18242.
15. Szabo R, Molinolo A, List K, et al., Matriptase inhibition by hepatocyte growth factor activator inhibitor-1 is essential for placental development. Oncogene 2007; 26: 1546-1556.
16. Szabo R, Kosa P, List K, et al., Loss of matriptase suppression underlies spint1 mutation-associated ichthyosis and postnatal lethality. Am J Pathol 2009; 174: 2015-2022.
17. List K, Bugge TH, Szabo R,. Matriptase: potent proteolysis on the cell surface. Mol Med 2006; 12: 1-7.
18. Oberst MD, Chen LY, Kiyomiya K, et al., HAI-1 regulates activation and expression of matriptase, a membrane-bound serine protease. Am J Physiol Cell Physiol 2005; 289: C462-470.
19. Godiksen S, Selzer-Plon J, Pedersen ED, et al., Hepatocyte growth factor activator inhibitor-1 has a complex subcellular itinerary. Biochem J 2008; 413: 251-259.
20. Hashimoto T, Kato M, Shimomura T, et al., TMPRSS13, a type II transmembrane serine protease, is inhibited by hepatocyte growth factor activator inhibitor type 1 and activates pro-hepatocyte growth factor. FEBS J 2010; 277: 4888-4900.
21. Fan B, Wu TD, Li W, et al., Identification of hepatocyte growth factor activator inhibitor-1B as a potential physiological inhibitor of prostasin. J Biol Chem 2005; 280: 34513-34520.
22. Tanaka H, Nagaike K, Takeda N, et al., Hepatocyte growth factor activator inhibitor type 1 (HAI-1) is required for branching morphogenesis in the chorioallantoic placenta. Mol Cell Biol 2005; 25: 5687-5698.
23. Kawaguchi M, Takeda N, Hoshiko S, et al., Membrane-bound serine protease inhibitor HAI-1 is required for maintenance of intestinal epithelial integrity. Am J Pathol 2011; 179: 1815-1826.
24. Cheng H, Fukushima T, Takahashi N, et al., Hepatocyte growth factor activator inhibitor type 1 regulates epithelial to mesenchymal transition through membrane-bound serine proteinases. Cancer Res 2009; 69: 1828-1835.
25. Fukushima T, Kawaguchi M, Yamasaki M, et al., Hepatocyte growth factor activator inhibitor type 1 suppresses metastatic pulmonary colonization of pancreatic carcinoma cells. Cancer Sci 2011; 102: 407-413.
26. Nakamura K, Hongo A, Kodama J, et al., The role of hepatocyte growth factor activator inhibitor (HAI)-1 and HAI-2 in endometrial cancer. Int J Cancer 2011; 128: 2613-2624.
27. Chen YW, Wang JK, Chou FP, et al., Regulation of the matriptase-prostasin cell surface proteolytic cascade by hepatocyte growth factor activator inhibitor-1 during epidermal differentiation. J Biol Chem 2010; 285: 31755-31762.
28. O'Sullivan B, Shap J,. New TNM staging criteria for head and neck tumors. Semin Surg Oncol 2003; 21: 30-42.
29. Bryne M, Jenssen N, Boysen M,. Histological grading in the deep invasive front of T1 and T2 glottic squamous cell carcinomas has high prognostic value. Virchows Arch 1995; 427: 277-281.
30. Fukushima T, Tezuka T, Shimomura T, et al., Silencing of insulin-like growth factor-binding protein-2 in human glioblastoma cells reduces both invasiveness and expression of progression-associated gene CD24. J Biol Chem 2007; 282: 18634-18644.
31. Miyata S, Uchinokura S, Fukushima T, et al., Diverse roles of hepatocyte growth factor activator inhibitor type 1 (HAI-1) in the growth of glioblastoma cells in vivo. Cancer Lett 2005; 227: 83-93.
32. Miyata S, Fukushima T, Kohama K, et al., Roles of Kunitz domains in the anti-invasive effect of hepatocyte growth factor activator inhibitor type 1 in human glioblastoma cells. Hum Cell 2007; 20: 100-106.
33. Kreppel M, Scheer M, Drebber U, et al., Impact of podoplanin expression in oral squamous cell carcinoma: clinical and histopathologic correlations. Virchows Arch 2010; 456: 473-482.
34. Yavrouian EJ, Sinha UK, Rice DH, et al., The significance of EphB4 and EphrinB2 expression and survival in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2008; 134: 985-991.
35. Han J, Kioi M, Chu WS, et al., Identification of potential therapeutic targets in human head and neck squamous cell carcinoma. Head Neck Oncol 2009; 1: 27.
36. Banerjee AG, Bhattacharyya I, Vishwanatha JK,. Identification of genes and molecular pathways involved in the progression of premalignant oral epithelia. Mol Cancer Ther 2005; 4: 865-875.
37. Vairaktaris E, Loukeri S, Vassiliou S, et al., EGFR and c-Jun exhibit the same pattern of expression and increase gradually during the progress of oral oncogenesis. In Vivo 2007; 21: 791-796.
38. Vairaktaris E, Ragos V, Yapijakis C, et al., FGFR-2 and -3 play an important role in initial stages of oral oncogenesis. Anticancer Res 2006; 26: 4217-421.
39. Zhang X, Hunt JL, Landsittel DP, et al., Correlation of protease-activated receptor-1 with differentiation markers in squamous cell carcinoma of the head and neck and its implication in lymph node metastasis. Clin Cancer Res 2004; 10: 8451-8459.
40. Lo JF, Yu CC, Chiou SH, et al., The epithelial-mesenchymal transition mediator S100A4 maintains cancer-initiating cells in head and neck cancers. Cancer Res 2011; 71: 1912-1923.
41. Liu SC, Bassi DE, Zhang SY, et al., Overexpression of cyclin D2 is associated with increased in vivo invasiveness of human squamous carcinoma cells. Mol Carcinog 2002; 34: 131-139.
42. Xie F, Ye L, Chen J, et al., The impact of metastasis suppressor-1, MTSS1, on oesophageal squamous cell carcinoma and its clinical significance. J Transl Med 2011; 9: 95.
43. Wong VC, Chen H, Ko JM, et al., Tumor suppressor dual-specificity phosphatase 6 (DUSP6) impairs cell invasion and epithelial-mesenchymal transition (EMT)-associated phenotype. Int J Cancer 2012; 130: 83-95.
44. Jung A, Schrauder M, Oswald U, et al., The invasion front of human colorectal adenocarcinoma shows co-localization of nuclear β-catenin, cyclin D1, and p16INK4A and is a region of low proliferation. Am J Pathol 2001; 159: 1613-1617.
45. Lin HS, Berry GJ, Fee WE, et al., Identification of tyrosine kinases overexpressed in head and neck cancer. Arch Otolaryngol Head Neck Surg 2004; 130: 311-316.
46. Mierke CT, Bretz N, Altevogt P,. Contractile forces contribute to increased glycosylphosphatidylinositol-anchored receptor CD24 facilitated cancer cell invasion. J Biol Chem 2011; 286: 34858-34871.
47. Niiya D, Egawa N, Sakamoto T, et al., Identification and characterization of Lutheran blood group glycoprotein as a new substrate of membrane-type 1 matrix metalloproteinase 1 (MT1-MMP): a systemic whole cell analysis of MT1-MMP-associating proteins in A431 cells. J Biol Chem 2009; 284: 27360-27369.
48. Sato H, Takino T,. Coordinate action of membrane-type matrix metalloproteinase-1 (MT1-MMP) and MMP-2 enhances pericellular proteolysis and invasion. Cancer Sci 2010; 101: 843-847.
49. Fukai K, Yokosuka O, Chiba T, et al., Hepatocyte growth factor activator inhibitor 2/placental bikunin (HAI-2/PB) gene is frequently hypermethylated in human hepatocellular carcinoma. Cancer Res 2003; 63: 8674-8679.